Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.2M
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
26.2M
-
Shares change
-
+358K
-
Total reported value, excl. options
-
$203M
-
Value change
-
+$537K
-
Put/Call ratio
-
1.6
-
Number of buys
-
54
-
Number of sells
-
-50
-
Price
-
$7.75
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q3 2023
132 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q3 2023.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.2M shares
of 55.2M outstanding shares and own 47.46% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (4.18M shares), EcoR1 Capital, LLC (3.85M shares), VANGUARD GROUP INC (2.48M shares), BlackRock Inc. (2.47M shares), FARALLON CAPITAL MANAGEMENT LLC (1.29M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.17M shares), Erste Asset Management GmbH (1.06M shares), DIMENSIONAL FUND ADVISORS LP (779K shares), GEODE CAPITAL MANAGEMENT, LLC (647K shares), and ACADIAN ASSET MANAGEMENT LLC (630K shares).
This table shows the top 110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.